Prestige Wealth Management Group LLC Incyte Corp Transaction History

Prestige Wealth Management Group LLC

$460 Million
Q3 2024

A detailed history of Prestige Wealth Management Group LLC transactions in Incyte Corp stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 132 shares of INCY stock, worth $9,378. This represents 0.0% of its overall portfolio holdings.

Number of Shares

132

Previous 132 -0.0%

Holding current value

$9,378

Previous $8,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$51.18 - $63.75 $5,220 - $6,502	-102 Reduced 43.59%	132 $8,000
Q1 2024 Apr 26, 2024	BUY	$56.55 - $66.59 $5,146 - $6,059	91 Added 63.64%	234 $13,000
Q4 2023 Apr 26, 2024	SELL	$52.16 - $64.19 $7,928 - $9,756	-152 Reduced 51.53%	143 $8,000
Q4 2023 Feb 08, 2024	SELL	$52.16 - $64.19 $7,928 - $9,756	-152 Reduced 51.53%	143 $8,000
Q3 2023 Apr 26, 2024	BUY	$57.77 - $65.93 $1,270 - $1,450	22 Added 8.06%	295 $17,000
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $1,270 - $1,450	22 Added 8.06%	295 $17,000
Q2 2023 Apr 26, 2024	SELL	$60.95 - $75.51 $2,255 - $2,793	-37 Reduced 11.94%	273 $16,000
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $2,255 - $2,793	-37 Reduced 11.94%	273 $16,000
Q1 2023 Apr 26, 2024	BUY	$70.23 - $86.01 $5,337 - $6,536	76 Added 32.48%	310 $22,000
Q1 2023 May 16, 2023	BUY	$70.23 - $86.01 $280 - $344	4 Added 1.31%	310 $22,000
Q4 2022 Feb 07, 2023	BUY	$67.18 - $84.11 $3,896 - $4,878	58 Added 23.39%	306 $24,000
Q3 2022 Nov 01, 2022	SELL	$66.18 - $82.86 $2,316 - $2,900	-35 Reduced 12.37%	248 $16,000
Q2 2022 Aug 10, 2022	BUY	$66.18 - $83.18 $132 - $166	2 Added 0.71%	283 $21,000
Q1 2022 May 05, 2022	SELL	$66.02 - $79.71 $594 - $717	-9 Reduced 3.1%	281 $23,000
Q4 2021 Feb 15, 2022	BUY	$63.34 - $74.11 $11,464 - $13,413	181 Added 166.06%	290 $22,000
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $5,768 - $7,057	-84 Reduced 43.52%	109 $8,000
Q2 2021 Aug 12, 2021	BUY	$79.87 - $87.53 $3,354 - $3,676	42 Added 27.81%	193 $16,000
Q1 2021 May 13, 2021	SELL	$76.02 - $100.5 $6,993 - $9,246	-92 Reduced 37.86%	151 $13,000
Q4 2020 Feb 17, 2021	BUY	$80.74 - $97.7 $1,534 - $1,856	19 Added 8.48%	243 $22,000
Q3 2020 Oct 26, 2020	BUY	$85.07 - $109.69 $2,977 - $3,839	35 Added 18.52%	224 $20,000
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $2,967 - $4,357	40 Added 26.85%	189 $20,000
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $4,612 - $6,275	73 Added 96.05%	149 $11,000
Q1 2019 Aug 16, 2019	SELL	$63.56 - $88.17 $10,932 - $15,165	-172 Reduced 69.35%	76 $7,000
Q4 2018 Apr 16, 2019	BUY	$58.5 - $69.94 $14,508 - $17,345	248 New	248 $16,000

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Account

Prestige Wealth Management Group LLC Incyte Corp Transaction History